Category: Catalyst Journey
Catalyst Hires VP, Oncology Drug Development to Accelerate Growth and Oncology Services Offerings Wilmington, NC, 12 June 2020 – Catalyst Clinical Research, a Wilmington-based award-winning clinical development and Read Now Catalyst Hires VP, Oncology Drug Development, to Accelerate Growth and Oncology Services Offerings Wilmington, NC, 12 June 2020 – Catalyst Clinical Research, a Wilmington-based award-winning clinical development and Read Now 
Catalyst Hires Chief Strategy Officer to Fuel Growth and Innovation Wilmington, NC, 13 May 2020 – Catalyst Clinical Research, a clinical development and global resourcing Read Now 
Selected Partner for Artelo Biosciences Deliver the Upcoming Phase 1B/2A Trial of their Synthetic Cannabinoid, ART27.13 Aptus Clinical has been Read Now 
Catalyst Acquired Triangle Biostatistics Durham, N.C. (5 March 2019) – Catalyst Clinical Research, LLC (“Catalyst”), a leading provider of Read Now 
Partnership with Cell and Gene Therapy Catapult Aptus Clinical and Cell and Gene Therapy Catapult announce their clinical service collaboration to support Read Now